Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Monoclonal Gammopathy of Undetermined Significance (MGUS)
Clinical Trial
NCT06140524Last updated: 1/2/2026
REGN
Regeneron Pharmaceuticals, Inc.